Vir Biotechnology Inc (VIR)

$9.44 0.12 (1.26%)

16:00 EDT VIR Stock Quote Delayed 30 Minutes

VIR Stock Earnings: Vir Biotechnology Beats EPS for Q1 2024

By InvestorPlace Earnings May 2, 2024

VIR stock results show that Vir Biotechnology beat analyst estimates for earnings per share the first quarter of 2024.

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio

3 Highly Rated Biotech Stocks to Buy for 300% Gains

Volume:

Previous Close -

Market Cap 1.26B

PE Ratio -2.35

EPS -4.01

Volume (Avg. Vol.) 786,762

Day's Range $9.36 - $9.72

52-Week Range $7.61 - $26.14

Dividend & Yield N/A (N/A)

VIR Stock Predictions, Articles, and Vir Biotechnology Inc News

From InvestorPlace
From the Web

3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave

By Shane Neagle, InvestorPlace Contributor Feb 14, 2024

Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.

7 Small-Cap Stocks to Buy BEFORE the Year-End Rally

By Muslim Farooque, InvestorPlace Contributor Nov 30, 2023

explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy

3 Bill Gates Stocks to Buy for Billionaire-Like Returns

By Will Ashworth, InvestorPlace Contributor Oct 27, 2023

Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less.

7 Biotech Stocks to Get In Now Before Investors Catch On

By John Blankenhorn, InvestorPlace Contributor Oct 23, 2023

Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.

7 Top-Rated Stocks That Will Boost Your Portfolio in 2023

By Josh Enomoto, InvestorPlace Contributor May 10, 2023

For those seeking to rise above the muck in a big way, these top-rated stocks to buy might accomplish just that.

The 7 Best Bargain Stocks to Buy for May 2023

By Josh Enomoto, InvestorPlace Contributor May 4, 2023

With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly.

7 Thrilling Biotech Stocks for Aggressive Investors to Buy

By Josh Enomoto, InvestorPlace Contributor Apr 5, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

The Top 7 Growth Stocks in Biotech

By Alex Sirois, InvestorPlace Contributor Mar 3, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

7 Healthcare Stocks That Will Be Big Winners in 2023

By Alex Sirois, InvestorPlace Contributor Jan 31, 2023

Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.

3 Biotech Stocks to Buy Now for Extraordinary Gains

By Muslim Farooque, InvestorPlace Contributor Sep 20, 2022

These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.

4 Undervalued Biotech Stocks to Add to Your Buy List

By Shanthi Rexaline Apr 20, 2022

These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 30, 2022

Rise and shine, investor! It's time to go over the biggest pre-market stock movers in our breakdown for Wednesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Dec 2, 2021

Good morning, trader! We're gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday!

VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.

By Samuel O'Brient, InvestorPlace Reporter Nov 30, 2021

Vir Biotechnology has a Covid-19 treatment that its CEO says will do well against new variants. Amid uncertainty, VIR stock is climbing.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Nov 30, 2021

Good morning, investor! We're starting off Tuesday with a breakdown of the biggest pre-market stock movers you need to know about!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 17, 2021

Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Mar 11, 2021

What did the stock market do today? Biden signed the American Rescue Plan, OCGN stock popped and CPNG stock came public.

VIR Stock: Why Vir Biotechnology Is Plunging Today

By Chris MacDonald, InvestorPlace Contributor Mar 3, 2021

VIR stock is plunging on some pretty unfavorable news about a trial being suspended for the company's prospective Covid-19 vaccine.

7 Biotech Stocks to Buy That Could Beat the Coronavirus

By Chris Lau, InvestorPlace Contributor Apr 1, 2020

These biotech stocks are all working on treatments that have the potential to beat the coronavirus. Don't just wait for a cure. Buy them now.

Vir Biotechnology GAAP EPS of -$0.86 beats by $0.15, revenue of $16.79M beats by $10.24M (NASDAQ:VIR)

From Seeking Alpha Feb 22, 2024

Vir Biotechnology reports beat on Q4 earnings: GAAP EPS of -$0.86, surpassing expectations by $0.15. Revenue of $16.79M beats estimates by $10.24M.

JP Morgan cuts Vir to neutral, cites hepatitis drug franchise concerns (NASDAQ:VIR)

From Seeking Alpha Jan 29, 2024

JP Morgan downgrades Vir Biotechnology (VIR) due in part to concerns over its viral hepatitis franchise and cash position. Read more here.

Vir Biotech (NASDAQ:VIR) to Close R&D Facilities and Slash Workforce

From TipRanks Dec 14, 2023

Vir Biotechnology (NASDAQ: VIR), an immunology company announced a strategic business update where it will aim to reduce its operational expenses and will focus on ...

Vir Biotechnology to shed 12% of workforce as part of corporate restructuring (NASDAQ:VIR)

From Seeking Alpha Dec 13, 2023

Vir Biotechnology (VIR) plans to cut its workforce by 12% and close two R&D facilities to focus on its hepatitis and antibody programs. Read more here.

From laggards to leaders: Small caps on the rise

From MarketBeat Nov 27, 2023

Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.

Is Vir Biotechnology Stock a Buy?

From The Motley Fool Aug 11, 2023

The biotech is out to prove that it isn't just a "pandemic stock."

Vir Biotechnology Inc (VIR)

VIR Stock Earnings: Vir Biotechnology Beats EPS for Q1 2024

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio

3 Highly Rated Biotech Stocks to Buy for 300% Gains

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Vir Biotechnology Inc (VIR)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VIR Stock Predictions, Articles, and Vir Biotechnology Inc News

Subscriber Sign in